Abstract
Ovarian physiology is intricately connected to hormonally regulated angiogenic response. Recent advances in the post genomic revolution have significantly impacted our understanding of ovarian function. In an angiogenesis perspective, the ovary offers a unique opportunity to unravel the molecular orchestration of blood vessel development and regression under normal conditions. A majority of ovarian cancers develop from the single layer of epithelium surrounding the ovaries. Angiogenesis is critical for the development of ovarian cancer and its peritoneal dissemination. The present review summarizes recent findings on the angiogenic response in neoplastic ovaries and discusses the prospects of using anti-angiogenic approaches to treat ovarian cancer.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 169-182 |
| Number of pages | 14 |
| Journal | Angiogenesis |
| Volume | 8 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 2005 |
Bibliographical note
Funding Information:We thank Dr K.M. Burleson for critically reading the manuscript. This work is supported in part by the grants DA102104, DA011806, CA089652 from the National Institutes of Health, Minnesota Ovarian Cancer Alliance and Sparboe Endowment for Women’s Cancer Research.
Keywords
- Anginex
- Corpus luteum
- Endostatin
- Follicle
- Gene therapy
- Ovarian cancer
- Ovary
- VEGF
- VEGF-trap
